By Kamal Choudhury March 26 (Reuters) - Wave Life Sciences shares plunged 58% on Thursday after a higher dose of its experimental obesity drug failed to show a clear improvement at reducing a ...

By Siddhi Mahatole March 26 (Reuters) - Shares of Kodiak Sciences surged 68.6% to their highest in more than four years on ...

Shares of Kodiak Sciences surged sharply on Thursday after the biotechnology company reported positive results from a ...

Kodiak Sciences Inc. (NASDAQ:KOD) is one of the 10 Stocks Investors Dominating the Market Today. Kodiak Sciences soared by 74 ...

2026年3月26日，Kodiak Sciences宣布VEGF抗体聚合物Zenkuda治疗糖尿病性视网膜病变（DR）的三期临床GLOW2获得硬性结果。 受此消息影响，Kodiak Sciences当天股价大涨75%，市值达到24.6亿美元。

Investing.com -- Wave Life Sciences Ltd. (NASDAQ:WVE)股价周四下跌30%,此前该公司公布了其INLIGHT试验的中期1期数据,该试验正在评估WVE-007用于肥胖症治疗的效果。 Wave Life ...

Investing.com - 奥本海默在Wave Life Sciences(NASDAQ:WVE)公司公布其1期INLIGHT研究的临床更新后,重申了其跑赢大盘评级和32.00美元的目标价。该目标价相较当前12.30美元的股价显示出上涨潜力,不过InvestingPro数据显示,根据其公允价值分析,该股票目前的估值可能偏高。 该研究评估了WVE-007,其中240毫克剂量组在六个月时显示内脏脂 ...

近日，大橡科技凭借在类器官芯片领域的技术创新与服务能力，荣获国际权威杂志《Life Sciences ...

Wave Life Sciences (WVE) stock plunges as the company interim data from an early-stage trial for WVE-007, its RNA-based ...

Q4 2025 Management View Joseph Dowling, CEO, highlighted that "throughout 2025, we made meaningful progress against our top priorities, improving margins, reducing our cost structure and moving the ...

生命科学Life science在Trends in Biochemical Sciences创刊五十周年这个特别的时间节点，回顾本刊的创刊初衷与目标，令我倍受启发。1976年首期Trends in Biochemical ...

Q4 2025 Earnings Call March 26, 2026 4:30 PM EDTCompany ParticipantsBrendan Hawkins - Investor RelationsJoseph Dowling - ...